PACB compared with BLSH: revenue, margins and what each company keeps, and the suppliers and customers both name

PACBPacific Biosciences of California, Inc.

Mkt capRevenueRevenue

BLSHBullish

Mkt capRevenueRevenue

Compare

PACBPacific Biosciences of California, Inc.

BLSHBullish

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PACBPacific Biosciences of California, Inc.

2.36▼−9.60%· post 2.35

Mkt cap$728.9MRevenue$39MQ2 FY26Revenue$160MFY25

BLSHBullish

22.51▼−5.83%· post 22.56

ClosedNov 2 '26

Mkt cap$3.4BRevenue—Revenue—

Compare

ClosedNov 2 '26

PACBPacific Biosciences of California, Inc.

BLSHBullish

2.36▼−9.60%post 2.35

Price

22.51▼−5.83%post 22.56

$728.9M

Mkt cap

$3.4B

Q2 FY26$39M

Revenue

—

FY25$160M

Revenue

—

PACB2.36▼−9.60%vsBLSH22.51▼−5.83%ClosedNov 2 '26

Earnings history

last 4 reports each · paired by recencyMethod ›

PACB

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±37.4%▼−10.38%×0.28

Q1 FY26±12.1%▼−14.55%×1.21

Feb 13 '26±16.5%▼−7.07%×0.43

Jan 12 '26±10.9%▲+3.61%×0.33

BLSH

No earnings history for BLSH.

= impliedPACB realized, solidBLSH realized, hatchedOne scale, both sides: full bar = 38%× = |realized| ÷ impliedSource: market data